Not long ago, in September 2022, the WHO flagged four substandard cough syrup models from Maiden Pharma, India, as they were reportedly connected to the deaths of sixty six children in Gambia in western Africa. The item was later uncovered to possess abnormal levels of diethylene glycol and ethylene glycol as contaminants [thirteen].International: